Exagen Inc. (XGN) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Join SI Premium – FREE
Exagen Inc. (NASDAQ: XGN) reported Q2 EPS of ($0.21), $0.06 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $16.23 million.
For earnings history and earnings-related data on Exagen Inc. (XGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Iran to escalate tensions in region if diplomacy with U.S. fails - Reuters
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
